Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-3
Clinical trial NCT01984424 · COMPLETED
Trial details
- NCT number
- NCT01984424
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-10
- Primary completion
- 2015-11-10
- Enrollment
- 511
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.